BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magro F, Araujo F, Pereira P, Meireles E, Diniz-Ribeiro M, Velosom FT. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:1265-1274. [PMID: 15387356 DOI: 10.1023/b:ddas.0000037822.55717.31] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Gulubova MV, Manolova IM, Vlaykova TI, Prodanova M, Jovchev JP. Adhesion molecules in chronic ulcerative colitis. Int J Colorectal Dis. 2007;22:581-589. [PMID: 17109102 DOI: 10.1007/s00384-006-0236-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
2 Wang H, Machtaler S, Bettinger T, Lutz AM, Luong R, Bussat P, Gambhir SS, Tranquart F, Tian L, Willmann JK. Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. Radiology. 2013;267:818-829. [PMID: 23371306 DOI: 10.1148/radiol.13122509] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
3 Korolkova OY, Myers JN, Pellom ST, Wang L, M'Koma AE. Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol. 2015;8:29-44. [PMID: 26078592 DOI: 10.4137/cgast.s20612] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
4 Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 2008; 14(33): 5115-5124 [PMID: 18777587 DOI: 10.3748/wjg.14.5115] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
5 Harrington EO, Stefanec T, Newton J, Rounds S. Release of soluble E-selectin from activated endothelial cells upon apoptosis. Lung 2006;184:259-66. [PMID: 17235725 DOI: 10.1007/s00408-005-2589-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
6 Zhan H, Li H, Liu C, Cheng L, Yan S, Li Y. Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis. Front Immunol 2021;12:674343. [PMID: 34122433 DOI: 10.3389/fimmu.2021.674343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vaiopoulou A, Gazouli M, Theodoropoulos G, Zografos G. Current advantages in the application of proteomics in inflammatory bowel disease. Dig Dis Sci. 2012;57:2755-2764. [PMID: 22740064 DOI: 10.1007/s10620-012-2291-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
8 Wang H, Felt SA, Guracar I, Taviani V, Zhou J, Sigrist RMS, Zhang H, Liau J, Vilches-Moure JG, Tian L, Saenz Y, Bettinger T, Hargreaves BA, Lutz AM, Willmann JK. Anatomical Road Mapping Using CT and MR Enterography for Ultrasound Molecular Imaging of Small Bowel Inflammation in Swine. Eur Radiol 2018;28:2068-76. [PMID: 29170798 DOI: 10.1007/s00330-017-5148-6] [Reference Citation Analysis]
9 Gravina AG, Dallio M, Masarone M, Rosato V, Aglitti A, Persico M, Loguercio C, Federico A. Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets. Oxid Med Cell Longev 2018;2018:2568569. [PMID: 29849875 DOI: 10.1155/2018/2568569] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
10 Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol 2020;108:787-99. [PMID: 32182390 DOI: 10.1002/JLB.2MR0220-549R] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
11 Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”. World J Gastroenterol 2006; 12(12): 1829-1841 [PMID: 16609988 DOI: 10.3748/wjg.v12.i12.1829] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 84] [Article Influence: 4.9] [Reference Citation Analysis]
12 Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T, Owczarek D. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol 2016; 22(3): 1067-1077 [PMID: 26811647 DOI: 10.3748/wjg.v22.i3.1067] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
13 Voudoukis E, Karmiris K, Koutroubakis IE. Multipotent role of platelets in inflammatory bowel diseases: A clinical approach. World J Gastroenterol 2014; 20(12): 3180-3190 [PMID: 24696603 DOI: 10.3748/wjg.v20.i12.3180] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
14 Derkacz A, Olczyk P, Komosinska-Vassev K. Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases. Dis Markers. 2018;2018:7451946. [PMID: 29991970 DOI: 10.1155/2018/7451946] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011; 17(5): 578-593 [PMID: 21350707 DOI: 10.3748/wjg.v17.i5.578] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 91] [Article Influence: 8.3] [Reference Citation Analysis]
16 deZoeten EF, Battista KD, Colson SB, Lovell MA, Kessler BE, Isfort RW, Fennimore BP, Onyiah JC, Kao DJ, Yeckes A, Keely S, Murray M, Hoffenberg EJ, Colgan SP, Gerich ME. Markers of Hypoxia Correlate with Histologic and Endoscopic Severity of Colitis in Inflammatory Bowel Disease. Hypoxia (Auckl) 2020;8:1-12. [PMID: 32104717 DOI: 10.2147/HP.S219049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Bai R, Sun D, Chen M, Shi X, Luo L, Yao Z, Liu Y, Ge X, Gao X, Hu GF, Zhou W, Sheng J, Xu Z. Myeloid cells protect intestinal epithelial barrier integrity through the angiogenin/plexin-B2 axis. EMBO J 2020;39:e103325. [PMID: 32510170 DOI: 10.15252/embj.2019103325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]